Back to results
US 2024/0139334 A1Published application
Engineered liposomes for neutralization of sars-cov-2 and other enveloped viruses
AssigneeVanderbilt University
InventorsMichael R. KING, Zhenjiang ZHANG
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to engineered nanoparticles/liposomes that inhibit enveloped viruses and methods for use thereof.
Claims20
A method of neutralizing an enveloped virus comprising:
- a) providing a nanoparticle comprising a surface exposed cell receptor molecule that mediates entry of an enveloped virus into host cells;
- and
- b) administering the nanoparticle to an individual having or at risk of infection with the enveloped virus, wherein the cell receptor mediates a specific interaction event between the nanoparticle and the enveloped virus.
A nanoparticle comprising a surface exposed cell receptor molecule that mediates entry of an enveloped virus into host cells.
A kit comprising a nanoparticle comprising a surface exposed cell receptor molecule that mediates entry of an enveloped virus into host cells.
Dependencies are inferred from the claim text.